+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
RNA Interference Technology Market by Molecule Type, Route Of Administration, Delivery Method, Application, End-User - Global Forecast to 2030- Product Image
RNA Interference Technology Market by Molecule Type, Route Of Administration, Delivery Method, Application, End-User - Global Forecast to 2030- Product Image
Sale

RNA Interference Technology Market by Molecule Type, Route Of Administration, Delivery Method, Application, End-User - Global Forecast to 2030

  • PDF Icon

    Report

  • 183 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 4968963
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The RNA Interference Technology Market is witnessing substantial growth, advancing from USD 2.63 billion in 2024 to an anticipated USD 5.42 billion by 2030, with a projected CAGR of 12.76%. This expansion signifies RNA interference (RNAi) as a transformative technology in gene regulation and therapeutic development.

Unveiling the Promise of Gene Silencing with RNA Interference Technology

RNA interference represents a significant breakthrough in gene regulation, utilizing natural cellular mechanisms to target and silence specific mRNA transcripts. This precision enables the downregulation of harmful genes, providing a potent alternative to traditional therapies. RNAi's potential spans various diseases, including rare genetic conditions, cancer, and infectious diseases, with numerous candidates progressing into advanced clinical development stages. Strategic collaborations among academic, biotech, and pharmaceutical entities are set to further drive pipeline maturation over the next decade.

Redefining Therapeutic Possibilities through RNAi Innovations

Innovations in molecular design and delivery have reshaped the RNAi landscape. Advances in microRNA modulators and engineered RNA constructs have enhanced therapeutic durability. Delivery mechanisms, such as lipid nanoparticles and viral vectors, have overcome previous barriers, enabling safer systemic administration. Regulatory bodies’ growing acceptance of RNAi approaches accelerates market entry, supported by adaptive trials and accelerated reviews. These developments foster a flourishing competitive environment, encouraging partnerships and technological creativity.

Key Takeaways from This Report

  • Molecular innovations and delivery advancements are facilitating more potent RNAi therapies.
  • Increasing regulatory support and streamlined trial pathways are accelerating market readiness.
  • Collaborations are critical, leveraging cross-sector strengths for faster innovation cycles.

These insights emphasize strategic planning as essential for stakeholders seeking to secure competitive advantage through differentiated therapeutics and efficient processes.

Assessing the Economic Ripples of 2025 US Tariff Revisions on RNAi

In 2025, U.S. tariff updates on imported oligonucleotides and lab reagents introduced cost challenges in the RNAi supply chain. These changes have affected pricing and procurement cycles, pressuring both developers and smaller innovators. To mitigate these impacts, companies are localizing supply chains and refining procurement strategies to stabilize operations against tariff variabilities. These initiatives are vital for maintaining momentum in RNAi advancements.

Illuminating Growth Drivers through Detailed Market Segmentation

The market segmentation by molecule type, administration route, delivery method, and application reveals intricate therapeutic strategies. Targeted delivery innovations, like exosome-based systems and nanoparticle carriers, enhance treatment precision. RNAi facilitates advancements in drug discovery, R&D, and therapeutic applications, addressing various diseases. This segmentation helps decision-makers identify distinct growth areas and market opportunities.

Regional Dynamics Shaping the Global RNAi Market Landscape

In the Americas, robust funding and strong research infrastructures propel RNAi innovation, with the U.S. at the forefront. Europe and Middle Eastern countries present diverse regulatory landscapes, while Asia-Pacific shows exponential growth, driven by government support and manufacturing scale-up. These regional dynamics offer unique opportunities for strategic market entry and expansion.

Competitive Landscape Insights from Pioneers to Emerging Innovators

Established players in the RNAi market are setting new benchmarks in clinical outcomes and safety profiles. Emerging biotech firms are exploring cutting-edge technologies, while strategic partnerships across sectors enhance R&D productivity and open new markets. The shift towards precision therapies and gene-specific treatments underscores the sector's dynamism and competitive opportunities.

Strategic Imperatives for Navigating the RNAi Market Successfully

Leaders should invest in diverse delivery technologies and strengthen supply chain resilience. Focusing on personalized and rare disease therapeutics could unlock high-value market opportunities. Proactive regulatory engagement and strategic collaborations will streamline development pathways and expedite time-to-market, ensuring sustained innovation and differentiation.

Methodological Rigor Behind Comprehensive RNAi Market Analysis

The comprehensive analysis integrates extensive secondary research and primary interviews, ensuring data reliability and insight accuracy. This approach facilitates strategic insights that guide informed decision-making, ultimately propelling RNAi advancements.

The RNAi sector's growth is driven by significant scientific and commercial innovations. Understanding the intersection of molecule types, routes of administration, and delivery methods positions stakeholders to capitalize on emerging opportunities and mitigate risks.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising Prevalence of Genetic and Chronic Disorders Globally
5.1.1.2. Increasing Application of RNAi Technology in Drug Discovery & Development
5.1.1.3. Growing Need for Molecular Diagnostics
5.1.2. Restraints
5.1.2.1. Stringent FDA Regulations Regarding RNAi Therapies
5.1.3. Opportunities
5.1.3.1. Ongoing Research and Development in the Field of Nanotechnology and Cancer
5.1.3.2. State-of-the-art RNAi Therapies in Development
5.1.4. Challenges
5.1.4.1. Concerns in Delivery of RNA-Interference Therapies
5.2. Market Segmentation Analysis
5.2.1. Type: siRNA’s use for targeted gene therapy for treating a multitude of diseases
5.2.2. Application: Exponential adoption of RNA interference technology for dru discovery & development
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
5.5. Client Customization
6. RNA Interference Technology Market, by Type
6.1. Introduction
6.2. dsRNA
6.3. miRNA
6.4. siRNA
7. RNA Interference Technology Market, by Therapeutics
7.1. Introduction
7.2. Autoimmune Hepatitis
7.3. Hepatitis B and C
7.4. Neurological Disorders
7.5. Oncology
7.6. Respiratory Disorders
8. RNA Interference Technology Market, by Application
8.1. Introduction
8.2. Drug Discovery and Development
8.3. Therapeutics
9. Americas RNA Interference Technology Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific RNA Interference Technology Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa RNA Interference Technology Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.3.1. Switch Therapeutics Launches with USD 52 Million to Advance First-of-its-Kind RNAi Technology
12.3.2. Alnylam Pharmaceuticals and Medison Pharma Announce the Expansion of Their Collaboration to a Multi-Regional Partnership to Commercialize RNAi Therapeutics
List of Figures
FIGURE 1. RNA INTERFERENCE TECHNOLOGY MARKET RESEARCH PROCESS
FIGURE 2. RNA INTERFERENCE TECHNOLOGY MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 7. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2023 VS 2030 (%)
FIGURE 9. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 11. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. AMERICAS RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 13. AMERICAS RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. UNITED STATES RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 15. UNITED STATES RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. ASIA-PACIFIC RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. ASIA-PACIFIC RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. RNA INTERFERENCE TECHNOLOGY MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 21. RNA INTERFERENCE TECHNOLOGY MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. RNA INTERFERENCE TECHNOLOGY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. RNA INTERFERENCE TECHNOLOGY MARKET DYNAMICS
TABLE 7. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DSRNA, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY MIRNA, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY SIRNA, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY AUTOIMMUNE HEPATITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY HEPATITIS B AND C, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY RESPIRATORY DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 24. ARGENTINA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 25. ARGENTINA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 26. ARGENTINA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 27. BRAZIL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 28. BRAZIL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 29. BRAZIL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 30. CANADA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 31. CANADA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 32. CANADA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 33. MEXICO RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 34. MEXICO RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 35. MEXICO RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 37. UNITED STATES RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 38. UNITED STATES RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 39. UNITED STATES RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 40. ASIA-PACIFIC RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 41. ASIA-PACIFIC RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 42. ASIA-PACIFIC RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 43. ASIA-PACIFIC RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 44. AUSTRALIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 45. AUSTRALIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 46. AUSTRALIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 47. CHINA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 48. CHINA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 49. CHINA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 50. INDIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 51. INDIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 52. INDIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 53. INDONESIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 54. INDONESIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 55. INDONESIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 56. JAPAN RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 57. JAPAN RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 58. JAPAN RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 59. MALAYSIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 60. MALAYSIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 61. MALAYSIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 62. PHILIPPINES RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 63. PHILIPPINES RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 64. PHILIPPINES RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 65. SINGAPORE RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 66. SINGAPORE RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 67. SINGAPORE RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 68. SOUTH KOREA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 69. SOUTH KOREA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 70. SOUTH KOREA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 71. TAIWAN RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 72. TAIWAN RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 73. TAIWAN RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 74. THAILAND RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 75. THAILAND RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 76. THAILAND RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 77. VIETNAM RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 78. VIETNAM RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 79. VIETNAM RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 83. EUROPE, MIDDLE EAST & AFRICA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 84. DENMARK RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 85. DENMARK RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 86. DENMARK RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 87. EGYPT RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 88. EGYPT RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 89. EGYPT RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 90. FINLAND RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 91. FINLAND RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 92. FINLAND RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 93. FRANCE RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 94. FRANCE RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 95. FRANCE RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 96. GERMANY RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 97. GERMANY RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 98. GERMANY RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 99. ISRAEL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 100. ISRAEL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 101. ISRAEL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 102. ITALY RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 103. ITALY RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 104. ITALY RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 105. NETHERLANDS RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 106. NETHERLANDS RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 107. NETHERLANDS RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 108. NIGERIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 109. NIGERIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 110. NIGERIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 111. NORWAY RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 112. NORWAY RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 113. NORWAY RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 114. POLAND RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 115. POLAND RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 116. POLAND RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 117. QATAR RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 118. QATAR RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 119. QATAR RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 120. RUSSIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 121. RUSSIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 122. RUSSIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 123. SAUDI ARABIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 124. SAUDI ARABIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 125. SAUDI ARABIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 126. SOUTH AFRICA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 127. SOUTH AFRICA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 128. SOUTH AFRICA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 129. SPAIN RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 130. SPAIN RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 131. SPAIN RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 132. SWEDEN RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 133. SWEDEN RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 134. SWEDEN RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 135. SWITZERLAND RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 136. SWITZERLAND RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 137. SWITZERLAND RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 138. TURKEY RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 139. TURKEY RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 140. TURKEY RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 141. UNITED ARAB EMIRATES RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 142. UNITED ARAB EMIRATES RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 143. UNITED ARAB EMIRATES RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 144. UNITED KINGDOM RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 145. UNITED KINGDOM RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 146. UNITED KINGDOM RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 147. RNA INTERFERENCE TECHNOLOGY MARKET SHARE, BY KEY PLAYER, 2023
TABLE 148. RNA INTERFERENCE TECHNOLOGY MARKET, FPNV POSITIONING MATRIX, 2023

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this RNA Interference Technology market report include:
  • Alnylam Pharmaceuticals, Inc.
  • AMSBIO
  • Arbutus Biopharma Corporation
  • Arcturus Therapeutics Holdings Inc.
  • Arrowhead Pharmaceuticals, Inc.
  • Atalanta Therapeutics
  • Bioneer Corporation
  • Dicerna Pharmaceuticals, Inc.
  • Gradalis, Inc.
  • Horizon Therapeutics plc
  • Ionis Pharmaceuticals, Inc.
  • Merck KGaA
  • Novartis AG
  • Nutcracker Therapeutics, Inc.
  • Phio Pharmaceuticals Corp.
  • ProQR Therapeutics N.V.
  • Sanofi S.A.
  • Silence Therapeutics PLC
  • Sirnaomics, Inc.
  • Thermo Fisher Scientific Inc.
  • Vir Biotechnology, Inc.

Table Information

Report AttributeDetails
No. of Pages183
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 2.95 Billion
Forecasted Market Value ( USD ) by 2030 $ 5.42 Billion
Compound Annual Growth Rate12.7%
Regions CoveredGlobal
No. of Companies Mentioned22

Related Topics

Related Reports

RNA Interference (RNAi) - Global Strategic Business Report - Product Image

RNA Interference (RNAi) - Global Strategic Business Report

  • Report
  • 178 Pages
  • Global
From
RNA Interference- Pipeline Insight, 2025 - Product Image

RNA Interference- Pipeline Insight, 2025

  • Drug Pipelines
  • 204 Pages
  • Global
From
Antisense & RNAi Therapeutics Market Report 2025 - Product Image

Antisense & RNAi Therapeutics Market Report 2025

  • Report
  • 175 Pages
  • Global
From
RNAi Technologies and Global Markets - Product Image

RNAi Technologies and Global Markets

  • Report
  • 118 Pages
  • Global
From
RNA Interference Drug Delivery Market Report by Application, Technology, and Region 2025-2033 - Product Image

RNA Interference Drug Delivery Market Report by Application, Technology, and Region 2025-2033

  • Report
  • 150 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.